From: Atorvastatin protects endothelium by decreasing asymmetric dimethylarginine in dyslipidemia rats
Variables | Sham (n = 15) | Control (n = 15) | Low-dose (n = 15) | High-dose (n = 15) |
---|---|---|---|---|
Body weight (g) | 215.51 ± 2.70 | 213.24 ± 3.62 | 216.45 ± 2.82 | 215.26 ± 3.33 |
TG (mmol/L) | 1.03 ± 0.06 | 1.06 ± 0.08 | 1.03 ± 0.05 | 1.04 ± 0.07 |
TC (mmol/L) | 3.45 ± 0.11 | 3.52 ± 0.14 | 3.36 ± 0.15 | 3.44 ± 0.13 |
LDL-C (mmol/L) | 2.05 ± 0.10 | 2. 08 ± 0.12 | 2.06 ± 0.14 | 2.09 ± 0.12 |
HDL-C (mmol/L) | 0.93 ± 0.04 | 0.91 ± 0.04 | 0.90 ± 0.05 | 0.93 ± 0.03 |
FBG (mmol/L) | 4.06 ± 0.05 | 4.10 ± 0.08 | 4.08 ± 0.05 | 4.10 ± 0.08 |
NO (umol/L) | 11.73 ± 1.05 | 12.02 ± 1.14 | 11.81 ± 1.09 | 10.98 ± 1.04 |
CRP (mg/L) | 2.16 ± 0.32 | 2.28 ± 0.33 | 2.17 ± 0.22 | 2.32 ± 0.35 |
MDA (nmol/L) | 0.87 ± 0.04 | 0.90 ± 0.06 | 0.89 ± 0.03 | 0.93 ± 0.05 |
ADMA (ng/mL) | 42.52 ± 6.40 | 44.75 ± 5.33 | 43.90 ± 6.05 | 44.15 ± 5.20 |